Related references
Note: Only part of the references are listed.Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD
Kelsey Smith et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology
Johan Arnlov et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Daily Variability in Mineral Metabolites in CKD and Effects of Dietary Calcium and Calcitriol
Tamara Isakova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
Max Plischke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Steven E. Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Update on fibroblast growth factor 23 in chronic kidney disease
Myles Wolf
KIDNEY INTERNATIONAL (2012)
Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis
Wacharee Seeherunvong et al.
PEDIATRIC NEPHROLOGY (2012)
Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function
Justine Bacchetta et al.
PEDIATRIC NEPHROLOGY (2012)
C-terminal FGF23 is a strong predictor of survival in systolic heart failure
Damien Gruson et al.
PEPTIDES (2012)
Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase
Dagmar-Christiane Fischer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
Tamara Isakova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Jessica Kendrick et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the Second International Conference on Pediatric Cardiomyopathy
Paul F. Kantor et al.
PROGRESS IN PEDIATRIC CARDIOLOGY (2011)
Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure
Paolo G. Rusconi et al.
AMERICAN HEART JOURNAL (2010)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Biomarkers of Vascular Dysfunction in Children Infected With Human Immunodeficiency Virus-1
Tracie L. Miller et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease
Michael van Husen et al.
KIDNEY INTERNATIONAL (2010)
Regulation of calcium homeostasis and bone metabolism in the fetus and neonate
Deborah M. Mitchell et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
Heng Jung Hsu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2009)
Associations between neurohormonal and inflammatory activation and heart failure in children
Christopher Ratnasamy et al.
AMERICAN HEART JOURNAL (2008)
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
Diana M. Antoniucci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Theoretical and empirical derivation of cardiovascular allometric relationships in children
T Sluysmans et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
SL Ferrari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
International society for heart and lung transplantation: Practice guidelines for management of heart failure in children
D Rosenthal et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure
SE Lipshultz et al.
PEDIATRICS (2003)
Design and implementation of the North American Pediatric Cardiomyopathy Registry
MA Grenier et al.
AMERICAN HEART JOURNAL (2000)
Share Paper
